Rorze Lifescience to absorb Genostaff in internal merger, Genostaff dissolved Sept. 1, 2026

Rorze Corporation announced that Rorze Lifescience will absorb its subsidiary Genostaff in an internal merger, with Genostaff dissolving on September 1, 2026. This intra-group reorganization aims to consolidate management resources, improve efficiency, and strengthen competitiveness in the life science sector. The company expects the impact on consolidated financial results to be immaterial.

Rorze will merge two life science subsidiaries, with Rorze Lifescience absorbing Genostaff in an intra-group reorganization. * Genostaff will be dissolved; the absorption-type merger takes effect Sept. 1, 2026. * The group aims to consolidate management resources, lift efficiency, strengthen competitiveness in life science. * Impact on consolidated results expected to be immaterial. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rorze Corporation published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here